Clinuvel Pharmaceuticals Ltd. earnings per share and revenue

CLVLY earnings per share for the last semiannual are 0.14 USD whereas the estimation was 0.17 USD which accounts for -18.93% surprise. Company revenue for the same period amounts to 21.11 M USD despite the estimated figure of 23.06 M USD. Estimated earnings per share for the next semiannual are 0.30 USD, and revenue is expected to reach 37.48 M USD. Also watch annual changes over time to get a bigger picture of CLVLY earnings per share and revenue dynamics.